Insider · CIK 0002048706
Tadd S. Wessel
director
Files at PVLA (PALVELLA THERAPEUTICS, INC.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 10, 2025 | PVLA PALVELLA THERAPEUTICS, INC. | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +12,350 | $0.00 | $0 | 12,350 | Jun 11, 2025 |
| Dec 13, 2024 | PVLA PALVELLA THERAPEUTICS, INC. | AGrant or award Stock Option (right to buy)derivative | +24,700 | $0.00 | $0 | 24,700 | Dec 17, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.